FDA Inspection 1249246 — Apotex, Inc.
The FDA completed an inspection of Apotex, Inc. on September 27, 2024 in Etobicoke. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 27, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Etobicoke (Canada)
Additional Details
Bioanalytical BA/BE